Bronte Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111M | Buy |
|
|||||
|
2025
Q1 | $115M | Buy |
|
|||||
|
2024
Q4 | $128M | Buy |
|
|||||
|
2024
Q3 | $144M | Sell |
|
|||||
|
2024
Q2 | $147M | Sell |
|
|||||
|
2024
Q1 | $140M | Sell |
|
|||||
|
2023
Q4 | $128M | Buy |
|
|||||
|
2023
Q3 | $116M | Buy |
|
|||||
|
2023
Q2 | $99.4M | Buy |
|
|||||
|
2023
Q1 | $112M | Sell |
|
|||||
|
2022
Q4 | $103M | Sell |
|
|||||
|
2022
Q3 | $101M | Sell |
|
|||||
|
2022
Q2 | $88.2M | Buy |
|
|||||
|
2022
Q1 | $97.1M | Buy |
|
|||||
|
2021
Q4 | $82.4M | Buy |
|
|||||
|
2021
Q3 | $75.2M | Buy |
|
|||||
|
2021
Q2 | $65.6M | Buy |
|
|||||
|
2021
Q1 | $28.1M | Buy |
|
|||||
|
2020
Q4 | $9.21M | Buy |
|